Skip to main content

Peer Review reports

From: Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer

Original Submission
12 Mar 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Mar 2021 Reviewed Reviewer Report
1 Apr 2021 Reviewed Reviewer Report
11 Apr 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 3
11 Apr 2021 Submitted Manuscript version 3
12 Apr 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 4
12 Apr 2021 Submitted Manuscript version 4
13 Apr 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 5
13 Apr 2021 Submitted Manuscript version 5
14 Apr 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 6
14 Apr 2021 Submitted Manuscript version 6
17 Apr 2021 Reviewed Reviewer Report
30 Apr 2021 Reviewed Reviewer Report
4 May 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 7
4 May 2021 Submitted Manuscript version 7
5 May 2021 Author responded Author comments - Mei-Jin Huang
Resubmission - Version 8
5 May 2021 Submitted Manuscript version 8
13 May 2021 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
19 May 2021 Editorially accepted
18 Jun 2021 Article published 10.1186/s12893-021-01273-5

You can find further information about peer review here.

Back to article page